We provide you with 20 years of free, institutional-grade data for THRD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of THRD. Explore the full financial landscape of THRD stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about THRD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Third Harmonic Bio, Inc.(NASDAQ:THRD) 
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by ...
Website: https://www.thirdharmonicbio.com
Founded: 2019
IPO Price: $17 (Sep 15, 2022)
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends